Unknown

Dataset Information

Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood-Derived Products Marketed as Stem Cell Therapies.


ABSTRACT:

Importance

The number of clinics marketing stem cell products for joint diseases, chronic pain, and most recently, COVID-19, has increased despite warnings from the US Food and Drug Administration that stem cell products for these and other indications have not been proven safe or effective.

Objective

To examine bacterial infections in 20 patients who received umbilical cord blood-derived products marketed as stem cell treatment.

Design, setting, and participants

This case series is a national public health investigation including case-finding, medical record review and abstraction, and laboratory investigation, including sterility testing of products and whole-genome sequencing of patient and product isolates. Participants included patients who developed bacterial in

SUBMITTER: Hartnett KP 

PROVIDER: S-EPMC8498849 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature